We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.82B
AUM Growth
-$235M
Cap. Flow
-$332M
Cap. Flow %
-18.22%
Top 10 Hldgs %
24.45%
Holding
188
New
30
Increased
38
Reduced
74
Closed
46

Top Buys

Rank Stock Value
1
PGNY icon
Progyny
PGNY
+$42.3M
2
LYFT icon
Lyft
LYFT
+$31.7M
3
CNXC icon
Concentrix
CNXC
+$24.7M
4
XRAY icon
Dentsply Sirona
XRAY
+$22.4M
5
GPN icon
Global Payments
GPN
+$21.4M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$31.5M
2
APTV icon
Aptiv
APTV
+$26.6M
3
ES icon
Eversource Energy
ES
+$22.4M
4
FTDR icon
Frontdoor
FTDR
+$22.4M
5
ETSY icon
Etsy
ETSY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.33%
2 Consumer Discretionary 13.44%
3 Healthcare 11.83%
4 Communication Services 9.64%
5 Consumer Staples 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WOOF icon
126
Petco
WOOF
$765M
$2.75M 0.15%
+603,635
New +$2.05M
PERI icon
127
Perion Network
PERI
$386M
$2.69M 0.15%
341,443
-68,736
-17% -$576K
BTG icon
128
B2Gold
BTG
$6.68B
$2.64M 0.14%
+855,844
New +$2.49M
SEE
129
DELISTED
Sealed Air
SEE
$2.52M 0.14%
69,397
-8,698
-11% -$304K
TBRG
130
DELISTED
TruBridge
TBRG
$2.36M 0.13%
197,674
+51,825
+36% +$603K
SNAP icon
131
Snap
SNAP
$9.05B
$2.35M 0.13%
+219,533
New +$2.5M
NAK
132
Northern Dynasty Minerals
NAK
$953M
$2.32M 0.13%
6,997,729
+4,145,767
+145% +$1.45M
EAF icon
133
GrafTech
EAF
$205M
$2.19M 0.12%
166,028
-32,267
-16% -$269K
OXM icon
134
Oxford Industries
OXM
$556M
$2.14M 0.12%
+24,694
New +$2.27M
EZPW icon
135
Ezcorp Inc
EZPW
$1.67B
$2.12M 0.12%
+189,333
New +$2.07M
DOMO icon
136
Domo
DOMO
$189M
$1.92M 0.11%
256,055
-49,433
-16% -$377K
TBI
137
Trueblue
TBI
$323M
$1.85M 0.1%
234,647
-45,301
-16% -$408K
JOUT icon
138
Johnson Outdoors
JOUT
$501M
$1.81M 0.1%
50,064
-9,786
-16% -$360K
IPGP icon
139
IPG Photonics
IPGP
$3.61B
$1.62M 0.09%
21,776
-4,286
-16% -$320K
LEXX icon
140
Lexaria Bioscience
LEXX
$9.07M
$1.45M 0.08%
31,718
-2,520
-7% -$120K
RIVN icon
141
Rivian
RIVN
$23.7B
$920K 0.05%
82,012
-170,417
-68% -$2.45M
PETS icon
142
PetMed Express
PETS
$42.1M
$635K 0.03%
172,653
-33,332
-16% -$118K
ALIT icon
143
Alight
ALIT
$394M
– –
-23,646
Closed -$3.49M
APTV icon
144
Aptiv
APTV
$10.3B
– –
-378,306
Closed -$26.6M
BBY icon
145
Best Buy
BBY
$17.4B
– –
-32,215
Closed -$2.72M
CMRC
146
Commerce.com Inc Series 1
CMRC
$175M
– –
-363,752
Closed -$2.93M
BLCO icon
147
Bausch + Lomb
BLCO
$6.01B
– –
-762,451
Closed -$11.1M
CAE icon
148
CAE Inc. Common Shares
CAE
$8.64B
– –
-155,524
Closed -$2.89M
CUZ icon
149
Cousins Properties
CUZ
$4.83B
– –
-392,804
Closed -$9.09M
DOX icon
150
Amdocs
DOX
$6.22B
– –
-56,526
Closed -$4.46M
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Invenomic Capital Management held 188 positions worth $1.82B, down 11% from $2.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $332M in Q3 2024, closing 46 positions and reducing 74 holdings. Its most notable exit was Aptiv, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in Progyny worth $29.5M.

  • Invenomic Capital Management's largest Q3 2024 buy was Progyny: 1,760,706 shares worth $29.5M.
  • Invenomic Capital Management added most to Lyft in Q3 2024, an estimated $31.7M increase.
  • Invenomic Capital Management's biggest Q3 2024 reduction was Illumina, cutting an estimated $31.5M.
  • Invenomic Capital Management fully exited Aptiv in Q3 2024, selling an estimated $26.6M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.82B portfolio in Q3 2024.
  • Invenomic Capital Management opened 30 new positions and closed 46 in Q3 2024.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.82B.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.